About

Coho VC focuses on supporting early-stage ventures that operate at the intersection of life sciences and computer science. They provide funding and incubation for startups that are exploring advanced technologies aimed at engineering and manipulating biological systems. Their approach involves helping these companies reduce risks and scale their operations effectively. Unlike many other venture capital firms, Coho VC emphasizes the broader impact of their investments, aiming to create value that extends beyond financial returns by contributing to life-saving innovations and environmental protection. The goal of Coho VC is to foster the development of frontier technologies that can significantly improve lives and the health of the planet.

Simplify's Take

What believers are saying

• Increased interest in decentralized AI platforms suggests a growing market for collaborative AI.
• Successful funding of CartaBio highlights potential in multi-modal cell-based platforms.
• Generative AI in AR devices indicates a trend towards immersive human-computer interfaces.

What critics are saying

• Competition from decentralized AI platforms could challenge Coho VC's AI sector investments.
• Generative AI in AR may disrupt traditional markets, requiring rapid innovation from Coho VC.
• Advancements in biotechnology may lead to increased regulatory scrutiny for Coho VC's investments.

What makes Coho VC unique

• Coho VC focuses on early-stage deeptech investments, merging life and computer sciences.
• They support ventures at the frontier of technology, beyond traditional cap table value.
• Coho VC incubates companies early, providing support to derisk and scale innovations.

Help us improve and share your feedback! Did you find this helpful?

YesNo